Fig. 1From: Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancerComparison of histopathologic and immunohistochemistry findings between patients and their matched patient-derived xenografts (PDXs, F2 generation) of head and neck cancer squamous cell carcinoma (HNSCC). Left columns show hematoxylin and eosin-staining and right columns show immunohistochemical staining of p63, a marker of squamous cell carcinoma, from patients and the PDX of each model. Representative stained sections are shown (magnification: 200× in patient samples; scale bars = 100 μm)Back to article page